{"meshTagsMajor":["Genes, BRCA2","Genetic Predisposition to Disease"],"meshTags":["Base Sequence","Breast Neoplasms","Female","Genes, BRCA2","Genetic Predisposition to Disease","Heterozygote","Humans","Male","Middle Aged","Molecular Sequence Data","Mutation","Ovarian Neoplasms","Pedigree","Prostatic Neoplasms","Spain"],"meshMinor":["Base Sequence","Breast Neoplasms","Female","Heterozygote","Humans","Male","Middle Aged","Molecular Sequence Data","Mutation","Ovarian Neoplasms","Pedigree","Prostatic Neoplasms","Spain"],"genes":["BRCA2","BRCA2 gene","BRCA2 protein"],"organisms":["9606"],"publicationTypes":["Case Reports","Journal Article","Research Support, Non-U.S. Gov\u0027t"],"abstract":"We report a novel germline 5369delATTT mutation in BRCA2 gene, detected in a 45-year-old woman with bilateral breast cancer. This deletion was also detected in her father with prostatic cancer and her sister with breast cancer. The mutation originates a premature stop at codon 1723 of BRCA2 protein and has not been documented in any published report to the best of our knowledge.","title":"A novel BRCA2 mutation that segregates with breast and prostate cancer in a Spanish family.","pubmedId":"19288190"}